Abstract:
An organometallic compound represented by Formula 1A: wherein, in Formula 1A, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein M, L1, L2, n1, and n2 are the same as described in the specification.
Abstract:
Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus comprising the organic light-emitting device: M(L1)n1(L2)n2 Formula 1 wherein, in Formula 1, M, L1, L2, n1, and n2 are the same as described in the detailed description of the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein, in Formula 1, M is a transition metal, L1 is a ligand represented by Formula 2A, L2 is a ligand represented by Formula 2B, n1 is 1 or 2, wherein, when n1 is 2, two groups L1 are identical to or different from each other, n2 is 1 or 2, wherein, when n2 is 2, two group L2 are identical to or different from each other, the sum of n1 and n2 is 2 or 3, and L1 and L2 are different from each other wherein X1, ring CY1, ring CY2, ring CY14, R1 to R3, R11 to R14, Z1 to Z3, a1, a2, a3, b1, and c1 are the same as described in the description, and * and *′ in Formulae 2A and 2B each indicate a binding site to M in Formula 1.
Abstract:
An organometallic compound represented by Formula 1: wherein in Formula 1, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2, Formula 1 wherein M is selected from iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), and rhodium (Rd), and wherein L1 is a ligand represented by Formula 2A and L2 is a ligand represented by Formula 2B, and wherein L1 and L2 in Formula 1 are different from each other,
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein, Formula 1, M is a transition metal, L1 is a ligand represented by Formula 2 as provided herein, L2 is a ligand represented by Formula 3 as provided herein, and n1 and n2 are each independently 1 or 2.
Abstract:
An organometallic compound represented by Formula 1 wherein, M1 to M4 are each independently a first-row transition metal, a second-row transition metal, or a third-row transition metal; X1 and X2 are each independently C(R5)(R6), Si(R5)(R6), N(R5), O, S, Se, or Te; W1 to W4 are each independently N(R7)(R8), P(R7)(R8), S(R7), a C5-C60 carbocyclic group unsubstituted or substituted with at least one R10a, or a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a; L1 to L6 are each independently a C1-C30 alkylene group unsubstituted or substituted with at least one R10a, a C5-C60 carbocyclic group unsubstituted or substituted with at least one R10a, or a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a, a3 to a6 are each independently an integer from 0 to 3, and R1 to R8 and R10a in Formula 1 are as described herein.
Abstract:
An organometallic compound represented by Formula 1
wherein, M1 to M4 are each independently a first-row transition metal, a second-row transition metal, or a third-row transition metal; X1 and X2 are each independently C(R5)(R6), Si(R5)(R6), N(R5), O, S, Se, or Te; W1 to W4 are each independently N(R7)(R8), P(R7)(R8), S(R7), a C5-C60 carbocyclic group unsubstituted or substituted with at least one R10a, or a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a; L1 to L6 are each independently a C1-C30 alkylene group unsubstituted or substituted with at least one R10a, a C5-C60 carbocyclic group unsubstituted or substituted with at least one R10a, or a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a, a3 to a6 are each independently an integer from 0 to 3, and R1 to R8 and R10a in Formula 1 are as described herein.